Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel-resistant prostate cancer cells (PC-3/R and DU-145/R)

Simple item page
dc.contributor.authorSurmeli, Z
dc.contributor.authorBozkurt, E
dc.contributor.authorOzer, O
dc.contributor.authorAtmaca, H
dc.contributor.authorKisim, A
dc.contributor.authorUzunoglu, S
dc.contributor.authorUslu, R
dc.contributor.authorKaraca, B
dc.date.accessioned2024-07-18T12:00:21Z
dc.date.available2024-07-18T12:00:21Z
dc.identifier.issn0732-183X
dc.identifier.other1527-7755
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/7659
dc.language.isoEnglish
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.titleEnhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel-resistant prostate cancer cells (PC-3/R and DU-145/R)
dc.typeMeeting Abstract

Files

Collections

Web of Science Koleksiyonu